Used for: Melanoma with a BRAF V600E mutation · Erdheim-Chester disease with a BRAF V600 mutation · 1 more
How to pay the least
Ask for the cash price
Zelboraf
We didn’t find one.
What to do
Ask your pharmacy for Zelboraf’s cash price, and one or two other pharmacies too.
Other ways
Free from the maker, if you qualify Genentech Patient Foundation. Do not have insurance coverage for their Genentech medicine and their household makes less than $150,000 per year Or call (888) 941-3331.
ZELBORAF ® is a kinase inhibitor indicated for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E mutation as detected by an FDA-approved test.
ZELBORAF® is indicated for the treatment of patients with Erdheim- Chester Disease with BRAF V600 mutation.
Limitation of Use: ZELBORAF is not indicated for treatment of patients with wild-type BRAF melanoma
Source: the FDA label for Zelboraf (Genentech, Inc.), August 28, 2026. Full label on DailyMed
Good to know
“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Check the maker’s page for who can use it.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.
Prices checked November 17, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/zelboraf/